Keratoconus Epidemiology Forecast till 2030

September 07 19:32 2020
Keratoconus Epidemiology Forecast till 2030

DelveInsight Business Research LLP
DelveInsight’s “Keratoconus Epidemiology Forecast to 2030′ report delivers an in-depth understanding of the disease, historical and forecasted Keratoconus epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Keratoconus is an eye disorder characterized by progressive thinning and changes in the shape of the cornea.

Keratoconus Epidemiology Segmentation in the 7MM from 2017 to 2030

  • Total Diagnosed Prevalent Population of Keratoconus
  • Severity-specific Distribution of Keratoconus
  • Age-specific Distribution of Keratoconus

Keratoconus Epidemiology Insights

  • The total diagnosed prevalent population of Keratoconus in 7MM in 2017 was 1,602,427
  • Keratoconus affects both males and females equally 

  • The prevalent cases of Keratoconus in the United States in 2017
    • Mild Keratoconus- 121,010 cases
    • Moderate Keratoconus – 313,527 cases
    • Severe Keratoconus- 115,510 cases 
  • The diagnosed prevalent cases of Keratoconus in 2017
    • the United States – 550,047 
    • Germany -218,772
    • Italy – 171,676
    • Spain – 105,463  
    • Japan- 240,591

Scope of the Report

  • The Keratoconus report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Keratoconus Epidemiology Report and Model provide an overview of the risk factors and global trends of Keratoconus in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Keratoconus in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Keratoconus
  • The report provides the segmentation of the Keratoconus epidemiology

 

Request for sample pages
Table of contents

1. Key Insights 

2. Executive Summary of Keratoconus

3.  Keratoconus: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1.  Keratoconus Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1.  Keratoconus Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1.  Keratoconus Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1.  Keratoconus Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1.  Keratoconus Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1.  Keratoconus Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1.  Keratoconus Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1.  Keratoconus Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1.  Keratoconus Treatment and Management

6.2.  Keratoconus Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/dimapurnewsdesk/deccansamachar.org/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7